Stayble Therapeutics announces Dr Daisuke Sakai as new Scientific Advisor
Stayble Therapeutics AB ("Stayble" or the "Company") announces that the Company has strengthened its scientific advisory board with Professor Daisuke Sakai, MD, PhD, as new scientific advisor. Dr Sakai will bring experience from the Japanese perspective in the field of treating degenerative disc disease as well as herniated discs. His broad knowledge in the field will strengthen our current scientific advisory board.Dr Daisuke Sakai is an Associate Professor in the Department of Orthopaedic Surgery at Tokai University School of Medicine in Kanagawa, Japan. Sakai's main clinical interest is